Bryn Mawr Hospital Report issue

Academic/Hospital Phase 4
Founded: Philadelphia PA United States (1893)

Organization Overview

First Clinical Trial
2019
NCT04290208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Bryn Mawr Hospital | Bryn Mawr Hospital Foundation

Active Ingredients

Drugs in Phase 4 Trials (2)

acetaminophen (tylenol) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 4)

Pain, Postoperative (Phase 4)

Severe Acute Respiratory Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2